Sysmex (OTCMKTS:SSMXY) Sets New 1-Year Low - Here's Why

Key Points

• Sysmex Corporation shares hit a new 52-week low at $12.47, closing slightly higher at $12.96 with trading volume of 2,825 shares.
• The company recently reported a quarterly EPS of $0.05, missing the expected $0.12, alongside revenue of $717.09 million, which was below the anticipated $807.27 million.
• Zacks Research upgraded Sysmex's rating from "strong sell" to "hold," reflecting a cautious outlook with a current consensus rating also at "hold."

Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) reached a new 52-week low on Wednesday . The company traded as low as $12.47 and last traded at $12.96, with a volume of 2825 shares trading hands. The stock had previously closed at $12.92.

Wall Street Analyst Weigh In

Separately, Zacks Research raised shares of Sysmex from a "strong sell" rating to a "hold" rating in a research note on Thursday, August 14th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of "Hold".

Sysmex Trading Up 0.3%

The company has a debt-to-equity ratio of 0.12, a current ratio of 3.37 and a quick ratio of 2.49. The company has a market cap of $8.16 billion, a price-to-earnings ratio of 25.92 and a beta of 1.10. The business's fifty day moving average price is $15.04 and its 200 day moving average price is $16.93.

Sysmex (OTCMKTS:SSMXY - Get Free Report) last announced its earnings results on Wednesday, August 6th. The company reported $0.05 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.07). Sysmex had a net margin of 9.35% and a return on equity of 10.20%. The company had revenue of $717.09 million during the quarter, compared to the consensus estimate of $807.27 million. Research analysts anticipate that Sysmex Corporation ADR will post 0.57 earnings per share for the current fiscal year.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.